Skip to content

Mass General OB/GYN at SMFM Pregnancy Meeting 2024

The Society for Maternal-Fetal Medicine's Annual Meeting, The Pregnancy Meeting™, is the premier event for cutting-edge science in obstetrics where participants can connect with colleagues in maternal-fetal medicine. Learn about the research presented by the Department of Obstetrics and Gynecology at Massachusetts General Hospital.

Saturday, February 10

Session: Insights into Prenatal Ultrasound Screening

Postgraduate Course: Screening of the Fetal Brain and Central Nervous Center
Bryann Bromley, MD, Maternal-Fetal Medicine Specialist, Department of Obstetrics and Gynecology, Massachusetts General Hospital

Sunday, February 11

Session: Demystifying Medicaid for MFMs

Postgraduate Course: Health Equity Work via 1115 Waivers: A Health System Perspective
Allison S. Bryant, MD, MPH, Maternal-Fetal Medicine Specialist, Department of Obstetrics and Gynecology, Massachusetts General Hospital

Postgraduate Course: State of the States on Medicaid Expansion
Mark A. Clapp, MD, MPH, Maternal-Fetal Medicine Specialist, Department of Obstetrics and Gynecology, Massachusetts General Hospital

Session: Surgical Obstetrics, Cesarean Scar Pregnancy and Other Controversial Topics

Postgraduate Course: Introduction to Surgical Obstetrics
Christina Duzyj Buniak, MD, MPH, Course Chair, Maternal-Fetal Medicine Specialist, Department of Obstetrics and Gynecology, Massachusetts General Hospital

Postgraduate Course: The Breadth of CSEP Treatment: Dissecting the SFMF Guideline
Christina Duzyj Buniak, MD, MPH, Course Chair

Postgraduate Course: OB As the Second Victim, the Psychological Toll of High Stakes Surgery
Christina Duzyj Buniak, MD, MPH, Course Chair

Monday, February 12

Session: Advances in Complex Inpatient and Ambulatory Medical Care Before, During, and After Pregnancy

Postgraduate Course
Malavika Prabhu, MD, Course Chair, Maternal-Fetal Medicine Specialist, Department of Obstetrics and Gynecology, Massachusetts General Hospital

Postgraduate Course: Management of Type 2 Diabetes in 2024
Camille Powe, MD, Course Chair, Endocrinologist, Co-Director, Diabetes in Pregnancy Program, Diabetes Unit, Department of Obstetrics and Gynecology, Massachusetts General Hospital

Session: Updates and Emerging Trends in Perinatal Infectious Disease Management

Postgraduate Course: Hepatitis B/C - Updated Guidance on Hepatitis Screening, Management, and Vaccination
Malavika Prabhu, MD

Session: Obstetric Innovation

Scientific Forum: The Use of Natural Language Processing to Improve Pregnancy Outcomes
Mark A. Clapp, MD, MPH

Tuesday, February 13

Keynote Presentation

Foundation for SMFM Chair Address
Bryann Bromley, MD

Session II

Moderator, Oral Plenary
Bryann Bromley, MD

Session I

Poster 96: Maternal and Pregnancy Outcomes Following Management of Acute Appendicitis During Pregnancy in the United States
Malavika Prabhu, MD

Poster 108: Unique Maternal Immunoproteomic Signatures by Trimester and in Response to De Novo mRNA Vaccination
Andrea Edlow, MD, MSc
, Maternal-Fetal Medicine Specialist, Department of Obstetrics and Gynecology, Massachusetts General Hospital
Lydia Shook, MD, Maternal-Fetal Medicine Specialist, Department of Obstetrics and Gynecology, Massachusetts General Hospital

Poster 164: Adjunctive Azithromycin for Unscheduled Cesarean Delivery Complicated by Intraamniotic Infection
Taylor S. Freret, MD, EdM
, Maternal-Fetal Medicine Fellow, Department of Obstetrics and Gynecology, Massachusetts General Hospital
Mark A. Clapp, MD, MPH

Malavika Prabhu, MD

Poster 203: Predicting Prolonged Pushers: Risk Factors for Prolonged Second Stage at the Time of Full Dilation
Mark A. Clapp, MD, MPH

Poster 220: Telehealth Use and Patient Care Utilization Within One Year Postpartum
Mark A. Clapp, MD, MPH
Thomas P. Kishkovich, MD, Clinical Fellow in Obstetrics, Gynecology and Reproductive Biology, Massachusetts General Hospital

Poster 242: Impact of Unit Acuity on Postpartum Hemorrhage and Severe Maternal Morbidity
Logan Mauney, MD, Fellow in Maternal-Fetal Medicine, Massachusetts General Hospital
Mark A. Clapp, MD, MPH
Christina Duzyj Buniak, MD, MPH

Poster 243: A Standardized Anemia Protocol and Obstetric Clinic-based Intravenous Iron Center Reduces Anemia at Delivery Admission
Logan Mauney, MD
Jonathan Siden, MD
Mark A. Clapp, MD, MPH
Sarah N. Bernstein, MD
, Maternal-Fetal Medicine Specialist, Department of Obstetrics and Gynecology, Massachusetts General Hospital

Poster 244: An Anemia Protocol and Obstetric Clinic-based Iron Infusion Center Decreases Disparities in IV Iron Access
Logan Mauney, MD
Jonathan Siden, MD
Mark A. Clapp, MD, MPH
Sarah N. Bernstein, MD

Poster 248: Changes in Low-dose Aspirin Eligibility and Use Among Nullips After Updated USPSTF Guidance
Mark A. Clapp, MD, MPH
Taylor S. Freret, MD, EdM

Poster 256: Activity Restriction and Time From Diagnosis to Delivery Among Patients With Preterm Pre-eclampsia
Mark A. Clapp, MD, MPH
Matthew Mossayebi, MD, MPH, Resident, Department of Obstetrics and Gynecology, Massachusetts General Hospital 

Poster 270: A Cost-Effectiveness Analysis of Neuraxial Anesthesia and Number of Attempts for External Cephalic Version
Claire Packer, MD
Thomas P. Kishkovich, MD
Mark A. Clapp, MD, MPH

Poster 324: Assessing Provider Confidence in Counseling Patients About Peripartum Toxicology Testing
Molly Siegel, MD, Maternal-Fetal Medicine Specialist, Department of Obstetrics and Gynecology, Massachusetts General Hospital
Sarah N. Bernstein, MD

Session 2

Poster 413: Differential Exposure to Antenatal Steroids by Sociodemographic Factors Among Late Preterm Births
Mark A. Clapp, MD, MPH

Poster 414: County-level Antenatal Steroid Exposure Among Late Preterm Births, 2016-2021
Mark A. Clapp, MD, MPH

Poster 428: Cost-effectiveness of BRCA1 Testing at Time of Obstetrical Prenatal Carrier Screening for Cancer Prevention
Malavika Prabhu, MD

Poster 449: Early Term Induction of Labor After the ARRIVE Trial Dissemination
Taylor S. Freret, MD, EdM
Mark A. Clapp, MD, MPH

Poster 450: Changes in Low-dose Aspirin Use After Updated USPSTF and ACOG Guidance on Race
Taylor S. Freret, MD, EdM
Allison S. Bryant, MD, MPH
Mark A. Clapp, MD, MPH

Poster 452: Evaluating Updated Guidelines for Delivery Management of Severe Fetal Growth Restriction
Taylor S. Freret, MD, EdM
Mark A. Clapp, MD, MPH

Poster 484: Donor Gamete Status and Hypertensive Disorders of Pregnancy in Pregnancies Conceived With Assisted Reproductive Technologies
Camille Powe, MD

Poster 485: Association Between Perinatal Phthalate Metabolite Concentrations and Postpartum Glucose Levels: A Prospective Observational Study
Camille Powe, MD

Poster 497: Fetal Heart Tracing Changes at Peak Methadone or Buprenorphine Dose Appear Unrelated to NOWS Severity
Kathleen Koenigs, MD
Molly Siegel, MD
Mark A. Clapp, MD, MPH
Sarah N. Bernstein, MD

Poster 521: Association of Obstetric Comorbidity Index With Postpartum Hemorrhage in a Large Health System
Logan Mauney, MD
Christina Duzyj Buniak, MD, MPH
Mark A. Clapp, MD, MPH

Poster 630: Development and Validation of a Clinical Risk Prediction Model for Small-for-Gestational Age Infants
Mark A. Clapp, MD, MPH

Wednesday, February 14

Session 7

Oral Concurrent 74: Predictors of Intrauterine Vacuum-induced Device Failure in Management of Postpartum Hemorrhage: A Multicenter Experience
Logan Mauney, MD
Matthew Mossayebi, MD, MPH
Ilona T. Goldfarb, MD, Maternal-Fetal Medicine Specialist, Department of Obstetrics and Gynecology, Massachusetts General Hospital

Session 3

Poster 665: Widespread Maternal Immunity to RSV Suggests Naturally-occurring Antibodies Provide Incomplete Neonatal Protection: Implications for Vaccination
Andrea Edlow, MD, MSc
Lydia Shook, MD

Poster 784: Neonatal Outcomes Among Individuals With Depressed Fetal Heart Tracings at Methadone and Buprenorphine Peak Levels
Kathleen Koenigs, MD
Molly Siegel, MD
Mark A. Clapp, MD, MPH
Sarah N. Bernstein, MD

Poster 803: Impact of Labor and Delivery Unit Acuity on Labor Length and Risk of Cesarean Delivery
Logan Mauney, MD
Christina Duzyj Buniak, MD, MPH
Mark A. Clapp, MD, MPH

Poster 815: Treatment Effect Heterogeneity of Antenatal Steroids Among Late Preterm Births
Mark A. Clapp, MD, MPH

Poster 895: Induction of Labor at 40 weeks of Gestation After the ARRIVE Trial Dissemination
Taylor S. Freret, MD, EdM
Mark A. Clapp, MD, MPH

Poster 896: Induction of Labor in Low-risk Patients With Pre-pregnancy Obesity After the ARRIVE Trial
Taylor S. Freret, MD, EdM
Mark A. Clapp, MD, MPH

Poster 901National Trends and Outcomes in Births With Co-occurring Hypertensive Disorders of Pregnancy and Gestational Diabetes
Mark A. Clapp, MD, MPH

Session 4

Poster 969Prediction of Adverse Neonatal Outcomes at the Start of the Second Stage of Labor
Mark A. Clapp, MD, MPH

Poster 1000: Surgical Antibiotic Prophylaxis Among Patients Treated for Intraamniotic Infection
Taylor S. Freret, MD, EdM
Malavika Prabhu, MD
Mark A. Clapp, MD, MPH

Poster 1075: Male Fetal Sex Associated With Maternal Respiratory Failure in Infection: A Health Records-based Cohort Study
Logan Mauney, MD
Matthew Mossayebi, MD, MPH
Andrea Edlow, MD, MSc
Lydia Shook, MD

Poster 1145: Postnatal Growth Trajectories of Offspring Exposed to Maternal SARS-CoV-2 Infection: A Pandemic Era Cohort Study
Andrea Edlow, MD, MSc
Lydia Shook, MD

Poster 1146: Single-cell Transcriptomic Profiling of Hofbauer Cells Reveals Varied Baseline Functions and Cluster-specific Responses to SARS-CoV-2
Andrea Edlow, MD, MSc
Lydia Shook, MD